About the Book
This TWN report is on the measures required by countries lacking drug manufacturing capacity and wishing to import generic drugs and measures required by countries able and willing to export generic drugs and wishing to overcome the constraints imposed by TRIPS Article 31(f) that production under compulsory licence has to be supplied predominantly for the domestic market. It is based on the Decision of 30 August 2003 adopted by the WTO General Council.
This report is a supplement updating the Manual on Good Practices in Public-Health-Sensitive Policy Measures and Patent Laws, published by the Third World Network.
1. Overcoming the TRIPS Restriction on Pharmaceutical Imports by and Exports to Countries with Insufficient Manufacturing Capacity
(a) Background to the "Paragraph 6" issue in the Doha Declaration on the TRIPS Agreement and Public Health
(b) Problem of countries with insufficient or no manufacturing capacities
(c) In search of a solution
(d) The Decision and Statement
2. Conditions and Measures for Implementing the Waiver to the TRIPS Restriction
(a) Countries and situations where the waiver is not required
(b) General situation where the waiver is required
(c) Measures required by the importing country
3. Measures Required by the Exporting Country
(a) Notify the WTO
(b) Conditions of the compulsory licence
(c) Payment of compensation
(d) Regional arrangements
4. Additional Requirements under the WTO General Council Chairperson's Statement
5. Comment on the 'Dampening Effect' of the Conditions and Procedures in the Decision and Chairperson's Statement
6. Limited Area of Applicability of the Decision
US$8.00 for First World countries
US$6.00 for Third World countries
RM8.00 for Malaysia
Prices are inclusive of postage costs by airmail.
How to Order the Book
Contact Third World Network at 131 Jalan Macalister, 10400 Penang, Malaysia.
Email us for further information